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Impact of Simvastatin on Development of New-onset Diabetes Mellitus in Asian
Population: Three-year Clinical Follow up Results
Yoonjee Park, Seung-Woon Rha, Byoung Geol Choi, Se Yeon Choi, Cheol Ung Choi,
Hong Euy Lim, Jin Won Kim, Eung Ju Kim, Chang Gyu Park, Hong Seog Seo,
Dong Joo Oh
Korea University Guro Hospital, Seoul, Korea (Republic of)
Background: Although statin therapy is beneﬁcial for vascular diseases, the rela-
tionship between speciﬁc statin therapy and incidence of new-onset diabetes mellitus
(DM)remains uncertain. We evaluated the impact of Simvastatin therapyon the
development of new-onset DM from3-year clinicalfollow up datain a series of Asian
population.
Methods: A total of 3,436 consecutive patients who did not have DM were enrolled.
New-onset DMwas deﬁned as having a fasting blood glucose 126mg/dLor HbA1c
6.5%. Baseline characteristics between the Simvastatin and the control group were
propensity score matched (PSM, C-statics¼0.808). Three-year cumulative incidence
of new-onset DM was compared between the two groups.
Results: At baseline, patients in the Simvastatin group showed higher prevalence
ofelderly, male gender,dyslipidemia, coronary artery disease, smoking and alcoholic
history, and higher levels of HbA1c, fasting glucose, triglyceride, ﬁbrinogen,
and ALP. Three-year clinical follow up results showed a higher incidenceof
new-onset DM in the Simvastatin group (3.8% vs. 2%, p¼0.017). Following PSM
(C-statics¼0.808), the 2 groups were well balanced except for higher levels of
ﬁbrinogen, ALT, and ALP in the Simvastatin group. After adjustment, there was no
difference in the incidence of new-onset DMbetween the 2 groups up to 3years
(Figure).
Conclusion: In our study, the relationship between the use of Simvastatin and the
incidence of new-onset DM remains unclear. Long-term follow up with a larger study
population will be necessary for further information.S58 JACC Vol 63/12/Suppl S jTCTAP A-202
Is Acetyltransferase Activity an Indicator of BMS Condition in the Follow-up of
Coronary Stenting
David G. Iosseliani, Irina E. Kuznetsova
City Center of Interv. Cardioangiology, Moscow, Russian Federation
Background: In-stent stenosis remains one of the most thrilling problems of inter-
ventional cardiology, and the search of the ways of its solution includes the study of
causes andmechanisms of neointimal hyperproliferation. For this reason the study of the
impact of N-acetylation phenotype on the process of restenosis seems very interesting.
Methods: Retrospective study included 100 male patients aged 56,8  6,1 years on
the average, who received 116 coronary BMS for chronic CHD from December 2003
to January 2007. The patients have been selected for the study after control coronary
angiography performed in 7,2  2,2 months after PCI. The main inclusion criterion
was the presence of in-stent stenosis (Group 1, n¼50) and good mid-term results
(Group 2, control, n¼50) in the absence of known clinical and angiographic risk
factors for restenosis development. Baseline angiographic data of patients and im-
mediate results of PCI were evaluated by two independent experts. The standard
Sulphadimine was used as the test-agent. After single peroral intake of 500 mg of
Sulphadimine, the urine has been collected for 6 hours, and than the ratio of pro-
metabolized (N-acetyl-sulphadimine) and non-metabolized sulphadimine in urine was
determined with the help of high-effective liquid chromatography.
Results: Among the studied patients, there were 38% slow acetylators and 62% fast
acetylators. The analysis of the distribution of acetylation phenotype on groups 1 and
2 revealed high statistically signiﬁcant prevalence of fast acetylators among patients
with in-stent stenosis in the mid-term after PCI, P¼0,0006.
Conclusion: We revealed reliable direct correlation between the velocity of acetyla-
tion processes and the degree of in-stent stenosis after coronary stenting with BMS in
patients with chronic coronary heart disease.
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The “4S” Law for the Management of Iatrogenic Aortocoronary Dissection:
Clinical Results and Importance of Immediate Bail-out Stenting
Shao-Ping Nie, Edmundo Patricio Lopes Lao, Xiao Wang, Yan Qiao,
Chang-Sheng Ma
Beijing Anzhen Hospital, Capital Medical University, Beijing, China
Background: Iatrogenic aortocoronary dissection is a rare but potentially disastrous
complication of percutaneous coronary intervention (PCI). However, there is a paucity
of data on the optimal initial management of this complication.The aim of this study
was to depict the characteristics and causes of iatrogenic aortocoronary dissection and
to elucidate the importance of a new strategy based on immediate bail-out stenting.
Methods: We collected 18 cases of iatrogenic aortocoronary dissection during PCI in
8 cardiac catheterization centers between 2005 and 2013, which were managed by a
single senior operator. A “4S” law based on immediate bail-out stenting performed
within 15 min was the initial strategy in most cases. The characteristics, treatment, and
in-hospital outcomes of the patients were evaluated.
Results: According to the NHLBI classiﬁcation, 15 patients (83.3%) had extensive
dissection (Type D to F) with acute closure (Type F) in 4 patients. In 3 patients
(16.7%), the dissections were diagnosed during coronary angiography, and in 15
patients (83.3%), during PCI. From the 18 patients, 16 patients (88.9%) underwent
bail-out stent implantation, with technical success in 14 patients. Among them, 13
patients followed the “4S” law, with 7.7  3.2 min from onset of dissection to
completion of bail-out stenting, and the procedural success rate was 100% with no
deaths. Two patients died due to time delay (stenting > 15min) and the third one died
due to hemodynamic collapse because the guidewire failed to cross the true lumen.
Conclusion: This study indicated that the “4S” law based on immediate bail-out
stenting is a feasible and efﬁcient strategy for the management of iatrogenic aorto-
coronary dissection.
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Abdominal Adiposity Measured with Dual Bioelectrical Impedance Analysis of
Hospitalized Patients in the Cardiology Ward
Kenji Sadamatsu, Kaoru Takegami, Taku Matsuura, Arihide Okahara,
Takaharu Shirahama, Daigo Mine, Yasuaki Koga, Yasutsugu Nagamoto,
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Background: Obesity is a well-known risk factor of cardiovascular disease. However,
several reports demonstrated “obesity paradox”, while central obesity was associated
with the highest risk of mortality, which suggests the signiﬁcance of visceral fat
measurement. Recently, a novel system with dual bioelectrical impedance analysis
(HDS-2000, Omron healthcare, Kyoto) was developed. This technique does not need
radiation exposure and the measurements were validated to have a good correlation
with computed tomography.
Methods: A total of consecutive 60 patients (69.3  10.6 years old, male 80%)
admitted to the department of cardiology were measured their visceral fat areas with
dual bioelectrical impedance analysis. Control group included 23 healthy volunteers
(31.5  8.3 years old, male 57%).
Results: The values of body mass index (24.0  4.6 vs 21.6  2.6, p¼0.03) and
visceral fat area (82.0  51.6 vs 46.1  15.7 cm2, p<0.01) in the hospitalized patientsApril 22–25, 2014 j TCTAP Abstracts/POSTER/Other (Unclassiﬁed)
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19th CardioVascular Summit: TCTAP 2014were signiﬁcantly larger than those of the volunteers. Although there was a positive
correlation between body mass index and visceral fat area (r¼0.86, p<0.01), the ration
of visceral fat area to body mass index was also higher in the hospitalized patients
(3.24  1.40 vs 2.11  0.61, p<0.01). Correlations of age to body mass index
(r¼0.09, p¼0.44) and visceral fat area (r¼0.16, p¼0.14) were not signiﬁcant, how-
ever, the ratio of visceral fat area to body mass index had a weak correlation to age
(r¼0.24, p¼0.03).
Conclusion: Hospitalized patients in the cardiology ward had larger visceral fat.
Further investigation is needed to demonstrate clinical usefulness of this novel
technique.
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The Protective Effect of PEP-1-CAT Fusion Protein Preconditioning on
Myocardial Ischemia-reperfusion Injury in Rats
Yongjun Zhang, Xiaolan Wang
The Sixth People’s Hospital Afﬁliated to Shanghai Jiaotong University, Shanghai,
China
Background: Myocardial infarction is a leading cause of death and disability, with a
direct correlation between infarct size and prognosis. Early reperfusion is an absolute
prerequisite for the survival of ischemic myocardium. However, reperfusion itself may
lead to accelerated and additional myocardial injury beyond that generated by
ischemia alone. Oxygen free radical theory is an important mechanism of ischemia-
reperfusion injury. hydroxyl, which has high High toxicity, can be removed by CAT.
in the stage of reperfusion,endogenous CAT is relative scanty. CAT does not readily
penetrate through membranes,but CAT can penetrate through cell TCTAP A-208
membranes by PEP-1. And PEP-1-CAT has Biological activity.
Methods: 40 Male rats were divided into 5 groups at random, Sham-operated group,
ischemia-reperfusion group(I/R group), PEP-1-CAT-treated group (group1,group2,
group3). 1ml NS were injected via caudal vein in Sham-operated group and ischemia-
reperfusion group, 100mg, 300mg and 500mg PEP-1-CAT were administered via
caudal vein respectively.7 hours later, the left main coronary artery was occluded for
30 minutes followed by a 2-h reperfusion in anesthetized rats, at the end of reperfu-
sion,hemodynamics were measured. Infarct size were measured by TTC staining, LDH,
CK in blood serum and MDA in myocardium were measured according to the manu-
facturer’s protocol. The myocardial cell apoptosis was determined with TUNEL (TdT-
mediated dUTP Nick-End Labeling) method. Immunoﬂuorescent method was used to
detect the expression changes of bcl-2 and bax in rat myocardium of left ventricle.
Results: Compared with I/R group, PEP-1-CAT-treated groups, LVSP anddp/dtmax
were increased(p<0.01), LVEDP were decreased(p<0.01). Cardiac infarct areas
appeared in each group, but the infarct size in PEP-1-CAT fusion protein groups were
signiﬁcantly lower than I/R group (p<0.05 or p<0.01). The myocardial MDA content
LDH and CK release were signiﬁcantly lower in PEP-1-CAT- treated groups than in I/R
group(p<0.01). Under the ﬂuorescent microscope, the apoptotic myocytes demon-
strated brilliant green ﬂuorescence and the percentage of apoptotic myocytes were
decreased signiﬁcantly in PEP-1-CAT-treated groups compared with I/R group
(p<0.01). DAPI marked nucleus demonstrated blue ﬂuorescence when excited under
UV light,whereas the expression of Bcl-2 and Bax protein in the cytoplasm as well as
nucleus membrane demonstrated brilliant green ﬂuorescence, some of which were
merged especially in bcl-2. Compared with I/R group, the drug group markedly
decreased the expression of Bax (p<0.01),the ratio of Bax to Bcl-2 was decent
incidentally.
Conclusion: PEP-1-CAT preconditioning has protective effect on ischemia-reperfu-
sion injury, this may be related with anti-oxidant and anti-apoptosis effect.
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Three-year Cumulative Incidence of New-onset Diabetes; Are There Differences
Between Atorvastatin and Simvastatin?
Sung gyu Yoon1, Seung-Woon Rha2, Byoung Geol Choi2, Se Yeon Choi2,
Cheol Ung Choi2, Chang Gyu Park2, Hong Seog Seo2, Dong Joo Oh2
1Yuseong Sun Hoapital, Daejeon, Korea (Republic of), 2Korea University Guro
Hospital, Seoul, Korea (Republic of)
Background: Chronic statin administration may be associated with modestly
increased risk of new-onset type 2 diabetes mellitus (T2DM). However, there were no
data whether there are different inﬂuence on the development of diabetes mellitus
between atorvastatin and simvastatin.
Methods: A total of 877 hyperlipidemia patients received statin and divided into 2
groups according to the type of statins; Atorvastatin group (n¼536) and Simvastatin
group (n¼242). 36-month cumulative incidence of new-onset T2DM were captured
and compared between the two groups.
Results: At baseline, patients in the atorvastatin group had a lower fasting glucose,
HDL-C, ﬁbrinogen, and higher history of angiotensin converting enzyme inhibitorJACC Vol 63/12/Suppl S j April 22–25, 2014 j TCTAP Abstracts/POST(ACEI) use. However, after propensity score matching, the two groups showed no
signiﬁcant difference at baseline. There was no signiﬁcant difference in cumulative
incidence of new-onset T2DM up to 36 months (Figure).
Conclusion: In our study, the cumulative incidence of new-onset T2DM up to 36
months were not different between chronic simvastatin and atorvastatin use.Peripheral Vascular Intervention
(Non-carotid, Non-neurovascular)
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Impact of Hemodialysis in Critical Limb Ischemia Patients with Infra-popliteal
Arterial Lesion on Clinical Outcomes Following Percutaneous Transluminal
Angioplasty
Sang-Ho Park1, Seung-Woon Rha2, Byoung Geol Choi2, Won-Yong Shin1,
Se Yeon Choi2, Yoonjee Park2, Akkala Raghavender Goud2, Hu Li2, Sunki Lee2,
Ji Bak Kim2, Sung Il Im2, Jin Oh Na2, Cheol Ung Choi2, Hong Euy Lim2,
Jin Won Kim2, Eung Ju Kim2, Chang Gyu Park2, Hong Seog Seo2, Dong Joo Oh2
1Soonchunhyang University Cheonan Hospital, Cheonan, Korea (Republic of),
2Korea University Guro Hospital, Seoul, Korea (Republic of)
Background: In general, it has been known that hemodialysis was associated with
vascular calciﬁcation and adverse clinical outcomes following endovascular inter-
vention (EVT). Although the success rate of infra-popliteal arterial lesion causing
critical limb ischemia (CLI) is becoming very high; however, the impact of hemo-
dialysis on the major clinical outcomes following successful EVT is not clariﬁed yet.
Methods: This study consisted of 115 consecutive CLI patients (pts) with infra-popliteal
arterial lesion underwent EVT from September 2006 to September 2010. Provisional
stenting was done once the balloon angioplasty outcome is not optimal, mainly by self-
expanding nitinol stents. 1-year clinical outcomes of hemolysis group (n¼89 pts) were
compared with those of non-hemolysis group (n¼26 pts) up to 12 months.
Results: The baseline clinical characteristics were similar between the two groups
except that the combined femoral arterial lesion (61.5% vs. 38.2%) was more frequent
in the hemodialysis group. 1-year repeat revascularization such as TLR, TER was
similar between the two groups. However, the incidence of unknown origin death
(16.7% vs. 0%, p¼0.006) and ostectomy (27.8% vs. 8.1%, p¼0.036) was higher in the
hemodialysis group (table).
Conclusion: In our study, at 1 year, despite of similar incidence of repeat revascu-
larization, the incidence of non-cardiac death and surgical intervention (ostectomy,
amputation, debriment) was higher in the hemodialysis group. Thus, CLI pts on he-
modialysis should be managed by more intensive care.ER/Other Pharmacologic Agents S59
